Brand Name*
|
Chemical Name
|
Usage in MS
|
amantadine
|
Fatigue
|
|
mineral oil+
|
Constipation
|
|
papaverine
|
Erectile dysfunction
|
|
Ampyra
|
dalfampridine (formerly called fampridine,
4-aminopyridine)
|
Walking
|
Antivert (US)
Bonamine (Can) |
meclizine
|
Nausea; vomiting; dizziness
|
Atarax
|
hydroxyzine
|
Paroxysmal itching
|
Avonex
|
interferon beta-1a
|
Disease-modifying agent
|
Bactrim; Septra
|
sulfamethoxazole
|
Urinary tract infections
|
Betaseron
|
interferon beta-1b
|
Disease-modifying agent
|
Botox
|
onabotulinumtoxin A
|
Spasticity in the upper limbs
|
Botox
|
onabotulinumtoxin A
|
Bladder dysfunction
|
Cialis
|
tadalafil
|
Erectile dysfunction
|
Cipro
|
ciprofloxacin
|
Urinary tract infections
|
Colace
|
docusate+
|
Constipation
|
Copaxone
|
glatiramer acetate
|
Disease-modifying agent
|
Cymbalta
|
duloxetine hydrochloride
|
Depression, pain (neuropathic)
|
Dantrium
|
dantrolene
|
Spasticity
|
DDAVP Nasal Spray
|
desmopressin
|
Urinary frequency
|
DDAVP Tablets
|
desmopressin
|
Urinary frequency
|
Decadron
|
dexamethasone
|
Acute exacerbations
|
Deltasone
|
prednisone
|
Acute exacerbations
|
Detrol (US)
|
tolterodine
|
Bladder dysfunction
|
Dilantin
|
phenytoin
|
Pain (dyesthesias)
|
Ditropan
|
oxybutynin
|
Bladder dysfunction
|
Ditropan XL
|
oxybutynin (extended release formula)
|
Bladder dysfunction
|
Dulcolax
|
bisacodyl+
|
Constipation
|
Effexor
|
venlafaxine
|
Depression
|
Elavil
|
amitriptyline
|
Pain (paresthesias)
|
Enablex
|
darifenacin
|
Bladder dysfunction
|
Enemeez Mini Enema
|
docusate stool softener laxative+
|
Constipation
|
Extavia
|
interferon beta-1b
|
Disease-modifying agent
|
Fleet Enema
|
sodium phosphate+
|
Constipation
|
Flomax
|
tamsulosin
|
Bladder dysfunction
|
Gablofen
|
baclofen
(intrathecal)
|
Spasticity
|
Gilenya
|
fingolimod
|
Disease-modifying agent
|
H.P. Acthar Gel
|
adrenocorticotropic
hormone (ACTH)
|
Acute exacerbations
|
Hiprex; Mandelamine
|
methenamine
|
Urinary tract infections
(preventative)
|
Hytrin
|
terazosin
|
Bladder dysfunction
|
Intrathecal Baclofen
(ITB Therapy)
|
baclofen (intrathecal)
|
Spasticity
|
Klonopin (US)
Rivotril (Can) |
clonazepam
|
Tremor; pain; spasticity
|
Laniazid; Nydrazid
|
isoniazid
|
Tremor
|
Levitra
|
vardenafil
|
Erectile dysfunction
|
Lioresal
|
baclofen
|
Spasticity
|
Macrodantin
|
nitrofurantoin
|
Urinary tract infections
|
Metamucil
|
psyllium hydrophilic mucilloid+
|
Constipation
|
Minipress
|
prazosin
|
Bladder dysfunction
|
MUSE
|
alprostadil
|
Erectile dysfunction
|
Neurontin
|
gabapentin
|
Pain (dysesthesias)
|
Nuedexta
|
dextromethorphan
+ quinidine
|
Pseudobulbar affect
|
Novantrone
|
mitoxantrone
|
Disease-modifying agent
|
Oxytrol (Oxybutynin Transdermal System)
|
oxybutynin
|
Bladder dysfunction
|
Pamelor (US)
Aventyl (Can) |
nortriptyline
|
Pain (parasthesias)
|
Paxil
|
paroxetine
|
Depression
|
Phillips' Milk of Magnesia
|
magnesium
hydroxide+
|
Constipation
|
Pro-Banthine
|
propantheline bromide
|
Bladder dysfunction
|
Prostin VR
|
alprostadil
|
Erectile dysfunction
|
Provigil
|
modafinil
|
Fatigue
|
Prozac
|
fluoxetine
|
Depression; fatigue
|
Pyridium
|
phenazopyridine
|
Urinary tract infections (symptom
relief)
|
Rebif
|
interferon beta-1a
|
Disease-modifying agent
|
Sanctura
|
trospium chloride
|
Bladder dysfunction
|
Sani-Supp suppository (US)
|
glycerin+
|
Constipation
|
Solu-Medrol
|
methylprednisolone
|
Acute exacerbations
|
Tegretol
|
carbamazepine
|
Pain (trigeminal neuralgia)
|
Tofranil
|
imipramine
|
Bladder dysfunction; Pain
|
Tysabri
|
natalizumab
|
Disease-modifying agent
|
Valium
|
diazepam
|
Spasticity (muscle spasms)
|
Vesicare (US)
|
solifenacin succinate
|
Bladder dysfunction
|
Viagra
|
sildenafil
|
Erectile dysfunction
|
Wellbutrin
|
bupropion
|
Depression
|
Zanaflex
|
tizanidine
|
Spasticity
|
Zoloft
|
sertraline
|
Depression
|
In a world where questions about Multiple Sclerosis seem to be endless, the confusion and chaos of a disease typically misunderstood and unknown will be overshadowed with a new sense of knowledge and freedom. Various topics of interest will be highlighted and discussed relating to MS in every aspect of a patient's life.
Wednesday, July 11, 2012
Medications used for MS Patients
Below is a list of medications most commonly used to treat MS. Those highlighted in red are the ones I've taken since being diagnosed six and a half years ago. Currently, I am not on any disease modifying treatments due to liver issues caused by the medications. Eventually, I'll begin treatment again.
Tuesday, July 10, 2012
MS Pain
It’s very difficult to express to others the specific pain that comes with an invisible disease. For me, I do everything I can to prevent anyone from noticing what MS does to me. Recently (within the last few months), the chronic pain I’ve experienced has gotten worse. Additionally, having to explain to others the pain I’m experiencing when I don’t even know how to comprehend it is frustrating and, well, sad. Unfortunately, most of the time when I’m experiencing an increase in pain, the questions I receive from others goes as far as angering me because, in my mind, these individuals should know if they are in my life. I’ve discovered that no one will ever truly comprehend the extent or complexity of MS unless they are in my (or another patient’s) shoes.
From an article in Overview of Pain as a Symptom of Multiple Sclerosis, MS pain is highlighted:
Furthermore, from A.S.A.M.I.E.F., MS pain is highlighted:Multiple sclerosis (MS) can be very painful, although many people do not realize the extent to which MS can cause pain and discomfort. I know that it is hard to find words to describe the MS hug or the incessant feeling like ants are biting the soles of your feet. However, the fact that these things are so unique to MS can result in a lack of understanding and empathy, just when you need it the most.
NEW HAVEN, Conn. (Reuters Health) - A large-scale survey of more than 7,000 multiple sclerosis (MS) patients shows that most MS patients are undertreated and often unrecognized for pain management.
Yale University neurologist Dr. Marco Rizzo presented these findings last week here at the 15th Yale Neuroimmunology Symposium.
``MS patients experience migraine headaches, eye, leg, facial, bladder and skin pain. Muscular spasms and prickling or tingling sensations of the skin are common, and the pain is chronic,'' Rizzo explained.
MS is a central nervous system disorder in which the thin protective coating called myelin that insulates nerve fibers in the brain and spine becomes damaged. Eventually, lesions develop in the brain and spinal cord that can lead to a loss of vision, weakness, numbness and tingling.
MS occurs when white blood cells known as T cells attack the proteins that make up myelin. Currently, there is no cure for the disease.
Chronic pain causes ``miswiring,'' leading to abnormal pain pathways, Rizzo noted. Typical pain medications do not work in chronic pain and so MS patients need to be treated with medications such as a class of antidepressants known as tricyclic antidepressants, and anticonvulsants. Typically, more than one medication or combination needs to be given in order to effectively tackle the pain, Rizzo pointed out.
Thursday, July 5, 2012
Tired vs. Fatigue
I've been asked numerous times about the differences in being tired and being fatigued. Below, an incredible piece from the Patient Experience highlights the differences:
…tiredness can […] be alleviated by rest. On the other hand fatigue is often the product of a chronic medical condition. It can lead to anxiety, light sensitivity, difficulty in sleeping and depression. Many people with fatigue go on find themselves almost in a state of delirium and exhaustion and it is difficult for them to carry on their previous lifestyles.On the News Medical web site Dr Olson said “”It is important to recognize the difference between tiredness and fatigue, because fatigue is a marker that the body is not able to keep up. The onset of the manifestations of fatigue, particularly if these are not normal states for you, should be taken seriously.”One of Dr Olson’s pieces of advice is to avoid caffeine and other stimulants which in the long term can lead to greater fatigue.
Monday, July 2, 2012
MS Facts
- More than 400,000 people in the United States have MS.
- An estimated 2,500,000 around the world have MS.
- About 45 percent of the people with MS are not severely affected by the disease.
- Diagnosis of MS is usually between 20 and 40 years of age.
- MS affects more women than men, with a ratio of 2:1.
- About 85 percent of those who are newly diagnosed have the relapsing-remitting form of MS.
- Without disease-modifying therapy, about 50 percent of those diagnosed with relapsing-remitting MS will become progressive at 10 years.
- Without disease-modifying therapy, about one-third of those diagnosed with relapsing-remitting MS will be using a wheelchair at 20 years.
- MS does not significantly affect life span.
- The course of the disease is unpredictable and no two people will experience the same set of symptoms.
- There are four types of MS: relapsing-remitting, secondary-progressive, primary progressive and progressive relapsing.
- Among young adults, MS is the most common disease of the central nervous system.
- Fatigue is one of the most common symptoms of MS.
- MS is not contagious.
- MS is a progressive disease for which there is not yet a cure.
- Increased understanding of MS has led to the development of many new treatments that target both the disease process and its many symptoms.
- Sclerosis is a Greek word meaning hardening of tissue or scars.
- MS is not inherited or genetically transmitted, although there does seem to be some genetic susceptibility to the disease.
*Conclusion* Part VI
As a patient who has had MS for over six years, returning to work and returning to the normal routine of daily life seemed near impossible. However, after being empowered with knowledge, although the understanding of the disease was far from over, it was easier to explain the progression and unpredictability of the disease to family, friends, colleagues, and employers. Additionally, the knowledge gained allowed for an easier transition back into the professional environment primarily due to explaining what accommodations may be needed. However, it is imperative to remember that simple accommodations used to help with fatigue, motor weakness, bowel and bladder control, loss of sensation, cognitive challenges, and unpredictability will allow an individual with MS to lead a much more productive and happy professional life.
Subscribe to:
Posts (Atom)